You-shan Zhao

No. 600, Yi Shan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1

Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

Deficiency of Setd2 in mesenchymal stem cells facilitates the progression of myelodysplastic syndrome to leukemia.

Deficiency of Setd2 in mesenchymal stem cells facilitates the progression of myelodysplastic syndrome to leukemia.

Journal: Molecular medicine (Cambridge, Mass.)

Published: July 16, 2025

Chidamide Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells from Patients with Myelodysplastic Syndromes

Chidamide Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells from Patients with Myelodysplastic Syndromes

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 25, 2024

Analysis of the influencing factors related to liver and cardiac iron overload in MDS patients detected by MRI in the real world.

Analysis of the influencing factors related to liver and cardiac iron overload in MDS patients detected by MRI in the real world.

Journal: Hematology (Amsterdam, Netherlands)

Published: January 25, 2021

Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients.

Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients.

Journal: Frontiers in oncology

Published: December 28, 2020

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.

Journal: Frontiers in oncology

Published: September 26, 2020

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations.

Journal: Scientific reports

Published: July 15, 2019

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.

Journal: Journal of translational medicine

Published: June 29, 2018

Inhibitory Effect of Decitabine on Proliferation of MDS-L Cells and Its Mechanism

Inhibitory Effect of Decitabine on Proliferation of MDS-L Cells and Its Mechanism

Journal: Zhongguo shi yan xue ye xue za zhi

Published: October 27, 2017

Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.

Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.

Journal: Leukemia research

Published: February 17, 2017

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.

Journal: Scientific reports

Published: September 05, 2016

TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes.

TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes.

Journal: British journal of haematology

Published: July 12, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026